Universal Beteiligungs und Servicegesellschaft mbH Purchases New Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 359,988 shares of the company's stock, valued at approximately $28,144,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.08% of GE HealthCare Technologies as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. CoreFirst Bank & Trust acquired a new stake in GE HealthCare Technologies during the 4th quarter valued at $25,000. Runnymede Capital Advisors Inc. purchased a new position in shares of GE HealthCare Technologies during the 4th quarter worth $28,000. LGT Financial Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 46.2% during the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after purchasing an additional 123 shares during the period. Accredited Wealth Management LLC purchased a new position in shares of GE HealthCare Technologies during the 4th quarter worth $30,000. Finally, Ameriflex Group Inc. purchased a new position in shares of GE HealthCare Technologies during the 4th quarter worth $31,000. Institutional investors and hedge funds own 82.06% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Piper Sandler reduced their price target on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. UBS Group raised GE HealthCare Technologies from a "sell" rating to a "neutral" rating and reduced their price target for the stock from $74.00 to $73.00 in a research note on Monday, May 5th. Morgan Stanley reduced their price target on GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. BTIG Research set a $95.00 price target on GE HealthCare Technologies and gave the stock a "buy" rating in a research note on Monday, April 14th. Finally, The Goldman Sachs Group reduced their price target on GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Three analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $88.27.

GE HealthCare Technologies Trading Down 0.6%

Shares of GEHC traded down $0.39 during trading hours on Monday, hitting $70.15. The stock had a trading volume of 2,396,175 shares, compared to its average volume of 3,447,779. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm has a market cap of $32.12 billion, a P/E ratio of 16.20, a P/E/G ratio of 3.19 and a beta of 1.21. The company's fifty day simple moving average is $68.74 and its 200 day simple moving average is $78.95. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.10. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $4.78 billion for the quarter, compared to analyst estimates of $4.66 billion. During the same period last year, the company posted $0.90 EPS. The business's quarterly revenue was up 2.7% on a year-over-year basis. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies announced that its Board of Directors has initiated a stock repurchase plan on Wednesday, April 30th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 3.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's management believes its shares are undervalued.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Friday, April 25th were issued a $0.035 dividend. The ex-dividend date of this dividend was Friday, April 25th. This represents a $0.14 annualized dividend and a yield of 0.20%. GE HealthCare Technologies's dividend payout ratio is currently 2.95%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.